Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
DKAM Donville Kent Asset Management Jason & Jesse | “VitalHub Reported Q1 Earnings – Cash Earnings +35%. Revenue $31.9M +47%, ARR $99.1M +34% (11% Organic), Adj. EBITDA $8.0M +42%, EBITDA Margin 25.1%, Cash Earnings $6.4M +35%, Cash Margin 20%. Profit margins continue to improve as they integrate the two deals done in 2025 and they should be back to previous high margins by Q3 2026. Their high margin ARR should continue to grow and add to the bottom line. They mentioned on their earnings call 'Great progress on AI in the quarter. Starting to see customer uptake and productivity internally.' They have two AI products actively in the market now. VitalHub currently has a relatively large amount of cash with no debt, and we expect some significant acquisitions in the second half of the year. They have historically compounded their cash earnings per share at more than 25% per year given high organic growth plus accretive acquisitions. The stock is currently trading like all other software stocks but given who their end customers are and earnings growing at +35% in the quarter, we believe it is only a matter of time before their earnings are given the respect they deserve.” | NEUTRAL | Q2 2026 Jul 10, 2026 | View Pitch |
DKAM Donville Kent Asset Management Jason & Jesse | “VitalHub is our only software investment at the moment. Government healthcare funding for digital tools, like the ones VitalHub offers, is growing in order to drive efficiency given the rising demand ” | BULL | Q1 2026 Apr 2, 2026 | View Pitch |
DKAM Donville Kent Asset Management Jason & Jesse | “VitalHub has built a premier healthcare SaaS solution that consistently generates over 20% organic growth. Supported by a substantial cash balance dedicated to M&A, the company demonstrates high operational resilience and compounding potential.” | BULL | Q4 2023 Dec 31, 2023 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.